| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AR-42 | GDSC1000 | pan-cancer | AAC | -0.05 | 0.2 |
| mRNA | istradefylline | CTRPv2 | pan-cancer | AAC | -0.088 | 0.2 |
| mRNA | BRD-K02251932 | CTRPv2 | pan-cancer | AAC | -0.061 | 0.2 |
| mRNA | CUDC-101 | GDSC1000 | pan-cancer | AAC | -0.05 | 0.2 |
| mRNA | BRD-K63431240 | CTRPv2 | pan-cancer | AAC | -0.056 | 0.2 |
| mRNA | BRD-A71883111 | CTRPv2 | pan-cancer | AAC | -0.058 | 0.2 |
| mRNA | CEP-701 | FIMM | pan-cancer | AAC | -0.22 | 0.2 |
| mRNA | salermide | CTRPv2 | pan-cancer | AAC | -0.071 | 0.2 |
| mRNA | Bicalutamide | GDSC1000 | pan-cancer | AAC | 0.054 | 0.2 |
| mRNA | BRD-K17060750 | CTRPv2 | pan-cancer | AAC | 0.059 | 0.2 |